» Authors » Kinya Inoue

Kinya Inoue

Explore the profile of Kinya Inoue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 199
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashimoto O, Nakamura A, Nakamura T, Iwamoto H, Hiroshi M, Inoue K, et al.
Nutr Cancer . 2013 Sep; 66(4):728-35. PMID: 24033329
It is agreed that many of the antitumor effects of (-)-epigallocatechin gallate (EGCG) are mediated by various other effects. We report a new finding, namely, the antiproliferation potential and mechanism...
2.
Inoue K, Torimura T, Nakamura T, Iwamoto H, Masuda H, Abe M, et al.
Clin Cancer Res . 2012 May; 18(14):3924-33. PMID: 22611027
Purpose: VEGF, EGF, and TGF-α are expressed in hepatocellular carcinomas (HCC) and play a role in its growth. Vandetanib, a multikinase inhibitor, suppresses the phosphorylation of VEGF receptor 2 (VEGFR-2)...
3.
Torimura T, Ueno T, Taniguchi E, Masuda H, Iwamoto H, Nakamura T, et al.
Cancer Sci . 2011 Dec; 103(3):542-8. PMID: 22151662
The drug delivery system to tumors is a critical factor in upregulating the effect of anticancer drugs and reducing adverse events. Recent studies indicated selective migration of bone marrow-derived endothelial...
4.
Iwamoto H, Torimura T, Nakamura T, Hashimoto O, Inoue K, Kurogi J, et al.
Neoplasia . 2011 Mar; 13(3):187-97. PMID: 21390182
Background: Metronomic chemotherapy involves frequent, regular administration of cytotoxic drugs at nontoxic doses, usually without prolonged breaks. We investigated the therapeutic efficacies of metronomic S-1, an oral 5-fluorouracil prodrug, and...
5.
Ueno T, Torimura T, Nakamura T, Sivakumar R, Nakayama H, Otabe S, et al.
Int J Mol Med . 2009 Jun; 24(1):17-22. PMID: 19513529
We examined whether or not epigallocatechin-3-gallate (EGCG) improves liver injury of nonalcoholic steatohepatitis (NASH) model mice expressing nuclear sterol regulatory element-binding protein 1c (nSREBP-1c) in adipose tissue. nSREBP-1c transgenic C57BL6...
6.
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, et al.
Liver Int . 2007 Sep; 27(8):1091-7. PMID: 17845537
Background/aims: C-reactive protein (CRP) was recently identified as a prognostic factor for patients with hepatocellular carcinoma (HCC) after surgical resection. We investigated the relationship between the serum levels of high...
7.
Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, et al.
Gastroenterology . 2007 Jul; 133(1):91-107.e1. PMID: 17631135
Background & Aims: We investigated whether endothelial progenitor cell (EPC) transplantation could reduce established liver fibrosis and promote hepatic regeneration by isolating rat EPCs from bone marrow cells. Methods: Recipient...
8.
Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, et al.
J Clin Gastroenterol . 2006 Oct; 40(10):942-8. PMID: 17063116
Objective: Surveillance of cirrhotic patients enables early detection of hepatocellular carcinoma (HCC) and possibly prolongs survival. The aim of this study was to explore whether early-stage HCC can be detected...
9.
Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, et al.
Liver Int . 2006 Aug; 26(7):781-8. PMID: 16911459
Background/aims: This study aimed to evaluate the usefulness of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (PET) and PET plus computed tomography (CT) fusion images for the detection of extrahepatic metastases of hepatocellular...
10.
Torimura T, Ueno T, Kin M, Taniguchi E, Nakamura T, Inoue K, et al.
Gastroenterology . 2006 Apr; 130(4):1301-10. PMID: 16618420
Background & Aims: Recent studies indicate that kringle 1-5 has a potent and specific antiangiogenic activity. Here, we investigated the antitumor effect of kringle 1-5 gene transfer on hepatocellular carcinoma...